[go: up one dir, main page]

MX2022009036A - Colageno dietetico no de animales. - Google Patents

Colageno dietetico no de animales.

Info

Publication number
MX2022009036A
MX2022009036A MX2022009036A MX2022009036A MX2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A
Authority
MX
Mexico
Prior art keywords
collagen
animal
naturally occurring
occurring polypeptides
free dietary
Prior art date
Application number
MX2022009036A
Other languages
English (en)
Inventor
Nikolay Ouzounov
Jeffrey R Mellin
Julia Co
Original Assignee
Geltor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltor Inc filed Critical Geltor Inc
Publication of MX2022009036A publication Critical patent/MX2022009036A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)

Abstract

En la presente se proporcionan polipéptidos de origen no natural que comprenden una secuencia de un fragmento de un colágeno y células recombinantes que contienen secuencias de ácido nucleico heterólogas que codifica paran para para los polipéptidos de origen no natural. Además, en la presente se proporcionan métodos no de animales para generar y purificar estos polipéptidos de origen no natural usando microorganismos, preferiblemente de células bacterianas.
MX2022009036A 2020-01-24 2021-01-22 Colageno dietetico no de animales. MX2022009036A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062965700P 2020-01-24 2020-01-24
US202063117243P 2020-11-23 2020-11-23
PCT/US2021/014714 WO2021150959A1 (en) 2020-01-24 2021-01-22 Animal-free dietary collagen

Publications (1)

Publication Number Publication Date
MX2022009036A true MX2022009036A (es) 2022-11-14

Family

ID=76991717

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009036A MX2022009036A (es) 2020-01-24 2021-01-22 Colageno dietetico no de animales.

Country Status (11)

Country Link
US (3) US11174300B2 (es)
EP (1) EP4093761A4 (es)
JP (1) JP7794745B2 (es)
CN (1) CN115298212A (es)
AU (1) AU2021211721A1 (es)
BR (1) BR112022014586A2 (es)
CA (1) CA3168802A1 (es)
GB (1) GB2610313B (es)
MX (1) MX2022009036A (es)
TW (1) TW202134267A (es)
WO (1) WO2021150959A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202111349QA (en) 2019-04-12 2021-11-29 Geltor Inc Recombinant elastin and production thereof
MX2022009036A (es) 2020-01-24 2022-11-14 Geltor Inc Colageno dietetico no de animales.
EP4376872A4 (en) * 2021-07-28 2025-10-29 Geltor Inc Pharmaceutical compositions and methods for treating connective tissue disorders with collagen polypeptides
CN118103024A (zh) * 2021-07-28 2024-05-28 格尔托公司 无动物化妆品胶原
WO2024238910A1 (en) * 2023-05-17 2024-11-21 Htl Biotechnology Innovation, Inc. Collagen production process
CN118255873B (zh) * 2024-04-30 2024-11-22 安徽中生安兰健康产业有限公司 重组人源iii型胶原蛋白及基因、表达载体、菌和应用

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
JP2000508544A (ja) 1996-04-12 2000-07-11 ファイブローゲン，インコーポレーテッド 組換えｄｎａ系におけるヒトプロコラーゲンおよびコラーゲンの合成
FR2757874B1 (fr) 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
WO2001034801A2 (en) * 1999-11-12 2001-05-17 Fibrogen, Inc. Recombinant gelatin in vaccines
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
TW499433B (en) * 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
CN1500876A (zh) * 2002-11-14 2004-06-02 �й������ž�����ҽѧ��ѧԺ����ҽ 一种编码鸡ⅱ型胶原蛋白的全长多核苷酸序列及其用途
EP1584630A1 (en) 2004-04-08 2005-10-12 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for preparing a modified protein outside a host cell
DE602006015289D1 (de) 2005-02-23 2010-08-19 Fujifilm Mfg Europe Bv Nicht-glycosylierte rekombinante collagen-ähnliche polypeptide
US7514531B2 (en) 2005-06-03 2009-04-07 The Texas A&M University System Specific binding sites in collagen for integrins and use thereof
US7495076B2 (en) 2005-10-13 2009-02-24 Gu Jennifer L Mineral collagen chelates and methods of making and using same
US7279329B2 (en) 2005-10-17 2007-10-09 Industrial Technology Research Institute Expression system for producing collagen
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
SI2004753T1 (sl) 2006-03-13 2010-06-30 Becker & Co Naturinwerk Termoplastični sestavki na osnovi kolagenskega prahu in kolagena za pripravo oblikovanih teles
EP2054442A2 (en) * 2006-06-14 2009-05-06 Cell-Matrix, Inc. Denatured collagen peptides and uses thereof
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
EP2220246B1 (en) 2007-10-26 2015-05-20 Collplant Ltd. Methods of processing recombinant procollagen
US7910134B2 (en) 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8507652B2 (en) 2008-02-08 2013-08-13 Luis Eduardo da Cruz Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
GB0820784D0 (en) * 2008-11-13 2008-12-24 Nordic Bioscience As Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments
US9382310B2 (en) 2009-02-06 2016-07-05 Rutgers, The State University Of New Jersey Expression of triple-helical collagen-like products in E. coli
CN103238071B (zh) * 2009-03-30 2016-07-06 北欧生物科技公司 纤维化生物标志物的测定
WO2011008303A2 (en) 2009-07-17 2011-01-20 The Texas A & M University System Designer collagens and uses thereof
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
CN103641896B (zh) * 2009-11-19 2015-08-05 浙江大学 明胶样单元的用途
US8946157B2 (en) * 2010-05-03 2015-02-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
US9040484B2 (en) 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
AU2012289916B2 (en) 2011-08-03 2017-08-03 Phoenix Tissue Repair, Inc. Collagen 7 and related methods
TWI592421B (zh) 2011-08-09 2017-07-21 双美生物科技股份有限公司 一種三重交聯之膠原蛋白、製造方法及其用途
RU2014115845A (ru) 2011-09-21 2015-10-27 Ливинг Пруф, Инк. Композиции и способы лечения состояний нарушенной барьерной функции кожи
WO2014050908A1 (ja) * 2012-09-26 2014-04-03 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
WO2014106830A1 (en) 2013-01-07 2014-07-10 Ramot At Tel-Aviv University Ltd. Jellyfish-derived polymer
US10053501B2 (en) 2013-03-21 2018-08-21 Commonwealth Scientific And Industrial Research Organisation Purification of triple helical proteins
US10155793B2 (en) 2013-09-09 2018-12-18 Commonwealth Scientific And Industrial Research Organisation Modified bacterial collagen-like proteins
US20160219910A1 (en) 2013-09-25 2016-08-04 Pronutria, Inc. Compositions and Formulations for Maintaining and Increasing Muscle Mass, Strength, and Performance and Methods of Production and Use Thereof
US10232008B1 (en) 2015-10-05 2019-03-19 Michael P. Moran Multi-purpose nutritional supplement composition
EP3373906B1 (en) 2015-11-09 2021-03-24 Shiseido Americas Corporation Compositions and methods for application over skin
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
CA3015685A1 (en) 2016-03-16 2017-09-21 Phoenix Tissue Repair, Inc. Methods of purifying collagen 7
CN106554410B (zh) 2016-06-02 2019-11-26 陕西东大生化科技有限责任公司 一种重组人源胶原蛋白及其编码基因和制备方法
CN106119322B (zh) 2016-07-22 2019-10-15 江苏江山聚源生物技术有限公司 一种提高重组人源胶原蛋白生产水平的发酵工艺
AU2017320520B2 (en) 2016-08-30 2024-09-19 Gelita Ag Use of collagen hydrolysate for improving endurance performance and for stimulating lipocatabolism
FR3058142B1 (fr) 2016-10-28 2023-11-24 Gelatines Weishardt Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament
CL2016003387A1 (es) 2016-12-29 2018-10-12 Univ De Santiago De Chile Usach Recubrimiento y/o película comestible para la conservación de productos cárneos
WO2019023555A1 (en) 2017-07-28 2019-01-31 Evelo Biosciences, Inc. POLYMER COMPOSITIONS
WO2019046943A1 (en) 2017-09-06 2019-03-14 University Of Ottawa PROTEINS OF THE COLLAGEN TYPE
US11180541B2 (en) * 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
GB201717134D0 (en) 2017-10-18 2017-12-06 Univ Swansea Monomeric collagen
SG11202004718QA (en) * 2017-11-22 2020-06-29 Geltor Inc Methods and systems for engineering collagen
DE102018104590A1 (de) 2018-02-28 2019-08-29 Gelita Ag Nutrazeutische oder pharmazeutische Zusammensetzung
AU2020253364A1 (en) * 2019-04-01 2021-10-28 Geltor, Inc. Topical formulations of recombinant collagens
AU2020286380B2 (en) 2019-06-03 2025-06-26 Société des Produits Nestlé S.A. Recover dietary supplement
MX2022009036A (es) 2020-01-24 2022-11-14 Geltor Inc Colageno dietetico no de animales.

Also Published As

Publication number Publication date
JP2023513435A (ja) 2023-03-31
US11332505B2 (en) 2022-05-17
US11174300B2 (en) 2021-11-16
BR112022014586A2 (pt) 2022-09-13
WO2021150959A1 (en) 2021-07-29
US20220332775A1 (en) 2022-10-20
US20210277075A1 (en) 2021-09-09
AU2021211721A1 (en) 2022-08-18
US20220017581A1 (en) 2022-01-20
TW202134267A (zh) 2021-09-16
EP4093761A1 (en) 2022-11-30
GB2610313B (en) 2024-07-03
EP4093761A4 (en) 2024-04-17
JP7794745B2 (ja) 2026-01-06
GB202212264D0 (en) 2022-10-05
GB2610313A (en) 2023-03-01
CN115298212A (zh) 2022-11-04
CA3168802A1 (en) 2021-07-29

Similar Documents

Publication Publication Date Title
MX2022009036A (es) Colageno dietetico no de animales.
SG149003A1 (en) Gene expression technique
IL86480A (en) Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
AR037583A1 (es) Metodo para producir l-aminoacidos utilizando bacterias que pertenecen al genero escherichia
NZ603996A (en) Cells or cell lines that stably express a bitter taste receptor and methods of making them
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
WO2003093417A3 (en) Lentiviral vector particles resistant to complement inactivation
WO2021248087A3 (en) Enzymes and regulatory proteins in tryptamine metabolism
WO2020243706A8 (en) Recombinant herpesvirales vector
PL1675956T3 (pl) Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
WO2020237066A3 (en) Gene editing in diverse bacteria
MX2022009200A (es) Vectores a base de poxvirus producidos por acido desoxirribonucleico (adn) natural o sintetico y usos de los mismos.
MX2012001672A (es) Vector que comprende promotor de manosa y promotor de manosa.
ZA202307543B (en) Faustovirus capping enzyme, mrna capping enzyme compositions, methods and kits
MX2022003203A (es) Polipéptidos de sintasa de ácido tetrahidrocannabinólico (thca) optimizados.
TW200604207A (en) A superantigen fusion protein and the use thereof
WO2020185669A3 (en) Fusion polypeptides
MX2023014979A (es) Metodo para producir linfocitos citoliticos naturales a partir de celulas madre pluripotentes.
WO2021231549A3 (en) Engineered gene-editing proteins
ZA202405905B (en) Faustovirus capping enzyme, mrna capping enzyme compositions, methods and kits
MX2024003963A (es) Acidos nucleicos que codifican polipeptidos factor viii con inmunogenia reducida.
WO2004046359A3 (en) Method of controlling gene expression in plants or plant cells
TW200639251A (en) Novel method of producing high plants and method of accelerating growth of high plants